TEK and glaucoma: To test our hypothesis that ~50% reduction of PTPRB activity might prevent the glaucoma phenotype in Tek+/- mice without the need to increase ligand availability, Tek+/-;PtprbNLS-LacZ/WT double heterozygous mice were generated, and enucleated eyes were collected.